Lv61
2920 积分 2023-10-23 加入
Chronic kidney disease
5天前
已完结
Phase 2b trial of inhaled imatinib for treatment of pulmonary arterial hypertension
6天前
已完结
Targeting PDGFR, EGFR, FGFR, and VEGFR: Key Receptor Tyrosine Kinases‐Driven Metabolic Reprogramming in Pulmonary Arterial Hypertension
11天前
已完结
Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease
19天前
已关闭
Cannabis-Based Products for Chronic Pain
1个月前
已完结
Advances in the Quest for Safe and Effective Drugs That Target the Cannabinoid Receptor Type 1 (CB1)
1个月前
已完结
Rational design of Gi-biased CB1 agonist with reduced side effects
1个月前
已完结
The c-Abl inhibitor IkT-148009 suppresses neurodegeneration in mouse models of heritable and sporadic Parkinson’s disease
3个月前
已完结
The endometrial carcinoma market
3个月前
已完结
Atopic dermatitis
4个月前
已完结
皖公网安备34019202002308
